Fist Assist Devices

Executive Summary

Fist Assist Devices is a US-based medical device company founded in 2019 and headquartered in Austin, Texas. The company has developed the Fist Assist (FA-1), a novel non-invasive wearable pneumatic compression device designed to dilate arm veins for arteriovenous (AV) fistula maturation in hemodialysis patients and to aid in phlebotomy procedures. The device aims to provide a low-cost, patient-empowering tool to improve vascular access outcomes and reduce healthcare costs associated with end-stage renal disease (ESRD). Given the high failure rate of AV fistulas due to inadequate maturation, the FA-1 addresses a significant unmet need in the dialysis access market. The company is currently in the early commercialization phase, with a focus on regulatory clearance and initial market entry in the United States. While specific funding and revenue figures are not yet public, the company's innovative approach and clear value proposition position it for potential growth in the vascular access device market.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) Clearance for FA-1 Device65% success
• H1 2027Pivotal Clinical Study Results (Maturation Success Rate)50% success
• 2027Strategic Partnership or Distribution Agreement with Dialysis Provider40% success